AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CYTARABINE
27 registrations across 4 African markets— 12 active
Markets with CYTARABINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CANCYT SOLUTION | 🇿🇼Zimbabwe | NAPROD LIFE SCIENCES PVT LTD | active | Dec 2027 |
| CYTOSAR 1000 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Sept 2025 |
| CIPLA CYTARABINE INJECTION 100 mg (1 ml) | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| CIPLA CYTARABINE INJECTION 100 (5 ml) | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| CIPLA CYTARABINE INJECTION 100 (10 ml) | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| CYTARABINE-FAULDING 20 mg/ml | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | suspended | May 2024 |
| LARACIT 100 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | suspended | Sept 2023 |
| LARACIT 500 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | suspended | Sept 2023 |
| ALEXAN 100 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Mar 2022 |
| ALEXAN 500 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Mar 2022 |
| CYTARABINE ACCORD Solution injectable / 100 MG | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Apr 2017 |
| CYTARABINE ACCROD Solution injectable / 1gr /10ml | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Apr 2017 |
| ARACYTINE Pdre p.prep.injectable / 1 gr | 🇹🇳Tunisia | PFIZER HOLDING FRANCE | expired | Jun 2009 |
| ALEXAN Solution injectable / 1 gr/20 ml | 🇹🇳Tunisia | EBEWE Pharma | expired | Apr 2007 |
| ALEXAN Solution injectable / 100 mg/5ml | 🇹🇳Tunisia | EBEWE Pharma | expired | Apr 2007 |
| ARACYTINE Pdre p.prep.injectable / 100 MG | 🇹🇳Tunisia | PFIZER HOLDING FRANCE | expired | Jul 1995 |
| CYTARABINE-FAULDING 100 mg/ml | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | active | Jan 1900 |
| P & U CYTARABINE CSV 500 mg / 25 ml INJECTION | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
| CYTOSAR 500 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
| P & U CYTARABINE CSV 100 mg/5 ml INJECTION | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
| CYTARABINE EBEWE SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ARACYTINE POUDRE POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARACYTINE POUDRE POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| CYTARABINE EBEWE SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ARACYTINE POUDRE POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARACYTINE POUDRE POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARACYTINE POUDRE POUR SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
CYTARABINE in Africa — Regulatory Overview
CYTARABINE is registered across 4 African markets with 27 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Tunisia, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 27 registrations, 12 (44%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.